ziprasidone
ziprasidone is a pharmaceutical drug with 86 clinical trials. Currently 1 active trials ongoing. Historical success rate of 90.0%.
Success Metrics
Based on 72 completed trials
Phase Distribution
Phase Distribution
5
Early Stage
12
Mid Stage
57
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
88.9%
72 of 81 finished
11.1%
9 ended early
1
trials recruiting
86
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Proposal To Develop A Rapid And Cost-Effective Diagnostic Test For Schizophrenia
Ziprasidone in Bipolar Disorder With Comorbid Lifetime Panic or Generalized Anxiety Disorder(GAD)
Efficacy and Safety of Iloperidone Compared With Placebo and Active Control in Subjects With Acute Schizophrenia
A Study to Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schizophrenia on Stable Doses of Antipsychotic Medication
Ziprasidone in Early Onset Schizophrenia Spectrum Disorders
Clinical Trials (86)
Proposal To Develop A Rapid And Cost-Effective Diagnostic Test For Schizophrenia
Ziprasidone in Bipolar Disorder With Comorbid Lifetime Panic or Generalized Anxiety Disorder(GAD)
Efficacy and Safety of Iloperidone Compared With Placebo and Active Control in Subjects With Acute Schizophrenia
A Study to Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schizophrenia on Stable Doses of Antipsychotic Medication
Ziprasidone in Early Onset Schizophrenia Spectrum Disorders
Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies
Ziprasidone in the Psychosis Prodrome
An Observational Drug Utilization Study of Asenapine in the United Kingdom (P08308)
Extension Study Evaluating The Safety And Tolerability Of Flexible Doses Of Oral Ziprasidone In Children And Adolescents With Bipolar I Disorder
Study Evaluating The Safety, Tolerability, And Efficacy Of Switching From Quetiapine To Ziprasidone
3-week Study to Evaluate Efficacy and Safety of Ziprasidone With Either Lithium or Divalproex in Acutely Manic Subjects
Extension Study of Patients Successfully Treated by Ziprasidone in Study A1281031
Treatment of Schizophrenic Patients With Ziprasidone
Adjunctive Ziprasidone in the Treatment of Bipolar I Depression
A Non-Interventional Post-Marketing Surveillance Study to Evaluate the Safety and Efficacy of Zeldox Capsule
Extension Study: Evaluating the Safety of Oral Ziprasidone in the Treatment of Subjects With Schizophrenia
A Study Comparing the Efficacy and Safety of Ziprasidone and Aripiprazole for the Treatment fo Schizophrenia or Schizoaffective Disorder in Hospitalized Patients
A Study Comparing the Efficacy and Tolerability of Ziprasidone vs. Clozapine for the Treatment of Schizophrenia in Patients Who Continue to Have Symptoms on or Cannot Tolerate Other Antipsychotic Drugs
Ziprasidone Pharmacokinetics Using a Reduced Food Effect Formulation Compared to Pharmacokinetics From Commercial Capsules
Non-interventional Study of Ziprasidone in the Treatment of Bipolar and Schizoaffective Disorders.
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 86